Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

GNRX
VanEck Vectors Generic Drugs ETF

  • Fund Description

    VanEck Vectors Generic Drugs ETF (GNRX) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Indxx Global Generics & New Pharma Index (IGNRXT), which is intended to track the overall performance of companies that derive a significant proportion of their revenues or that have the potential to derive a significant proportion of their revenues from the generic drug industry, or that have a primary business focus on the generic drug industry.

  •  
      

    • Fund Ticker

      GNRX
    • Exchange

      NASDAQ
    • Commencement

      01/12/2016
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      IGNRXT
    • Index Rebalancing

      Semi-Annual
  •  
    as of 03/23/17

    • 30-Day SEC Yield1

      0.07%
    • Total Net Assets

      $4.5M
    • Number of Holdings

      41
    • Options

      Expected
    • Gross Expense Ratio2

      5.70%
    • Net Expense Ratio/TER2

      0.55%
    • Distribution Frequency

      Annual
    • Next Distribution Date

      12/15/17
  • Key Points

    Industry may benefit from ongoing push to lower health care costs


    The only ETF offering global exposure to generic drug producers


    Positioned to take advantage of the expected growth of biosimilars

     

  • Trading Information

    • Fund Ticker

      GNRX
    • Index Total Return Ticker

      IGNRXT
    • NAV

      GNRXNV
    • Intraday NAV (IIV)4

      GNRXIV
    • Shares Outstanding

      200,000
    • Estimated Cash

      GNRXEU
    • Total Cash

      GNRXTC
    • CUSIP

      92189F577
    • ISIN

      US92189F5778
    Source: Bloomberg
  • Fees and Expenses2

    • Management Fee

      0.50%
    • Other Expenses

      5.20%
    • Gross Expense Ratio

      5.70%
    • Fee Waivers and
      Expense Reimbursement

      -5.15%
    • Net Expense Ratio/TER2

      0.55%
    2 Expenses for GNRX are capped contractually at 0.55% until at least February 1, 2018. Cap excludes certain expenses, such as interest.
  • Prices as of 03/23/17

    NAV/
    Last Price
    Volume
    30-Day Avg./
    Last Trading Day
    Daily Change
    NAV/
    Last Price
    YTD Change
    NAV/
    Last Price
    Premium/
    Discount
    Prem/Discount
    Distribution Charts
    NAV &
    Prem/Discount
    History
    NAV
    Chart
    GNRX $22.38
    $22.56
    2,498
    250
    $0.00 / +0.00%
    $0.15 / +0.67%
    +5.5%
    +5.1%
    $0.18
    0.78%
  • View All IndicesView All ETFsPerformance History: Average Annual Total Returns* (%)

    1 MO3 MOYTD1 YR3 YR5 YR10 YRLIFE
    01/12/16
    GNRX (NAV)5.713.726.45-2.52-------8.86
    GNRX (Share Price)6.762.625.92-3.00-------8.36
    IGNRXT (Index)5.863.816.42-1.63-------7.83
    Performance Differential (NAV - Index)-0.15-0.090.03-0.89-------1.03
    Quarter End as of 12/31/16
    1 MO3 MOYTD1 YR3 YR5 YR10 YRLIFE
    01/12/16
    GNRX (NAV)-2.57-12.45-----------15.40
    GNRX (Share Price)-3.11-11.79-----------14.45
    IGNRXT (Index)-2.45-11.62-18.91-18.91-------14.31
    Performance Differential (NAV - Index)-0.12-0.83-----------1.09
  • Daily HoldingsTop 10 Holdings (%)  as of 02/28/17

    Total Holdings: 79
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Sun Pharmaceutical Industries Ltd
    SUNP IN
    43,695
    444,2426.55
    Teva Pharmaceutical Industries Ltd
    TEVA US
    11,635
    407,4586.01
    Mylan Nv
    MYL US
    9,712
    406,4475.99
    Ucb Sa
    UCB BB
    3,532
    252,1183.72
    Albemarle Corp
    ALB US
    2,041
    207,1823.06
    Celltrion Inc
    068270 KS
    2,222
    199,3682.94
    Perrigo Co Plc
    PRGO US
    2,601
    194,4772.87
    Lupin Ltd
    LPC IN
    8,189
    180,7832.67
    Aspen Pharmacare Holdings Ltd
    APN SJ
    8,287
    179,4462.65
    Lonza Group Ag
    LONN VX
    961
    177,4912.62
    Top 10 Total (%)39.08
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.
  • Country Weightings (%) as of 02/28/17

    • Country

      % of Net Assets
    • UNITED STATES

      28.53
    • INDIA

      23.65
    • JAPAN

      8.03
    • CHINA

      7.64
    • SOUTH KOREA

      7.18
    • ISRAEL

      6.01
    • BELGIUM

      3.72
    • SOUTH AFRICA

      2.65
    • SWITZERLAND

      2.62
    • JORDAN

      1.72
    • INDONESIA

      1.44
    • FINLAND

      1.36
    • HUNGARY

      1.11
    • TAIWAN

      1.03
    • GERMANY

      1.01
    • SPAIN

      0.74
    • IRELAND

      0.66
    • AUSTRALIA

      0.45
    • CANADA

      0.29
    • Other/Cash

      0.17
  • Sector Weightings (%) as of 02/28/17

    • Sector

      % of Net Assets
    • Health Care

      96.8
    • Materials

      3.1
    • Other/Cash

      0.2